July 10, 2018 / 9:59 PM / in 8 months

Bayer, J&J put Xarelto MDL appeals push on hold pending SCOTUS review

A federal judge overseeing the multidistrict litigation over Bayer AG and Johnson & Johnson’s blood thinner Xarelto on Monday granted the companies’ request to withdraw motions for summary judgment and interlocutory appeal pending a decision by the U.S. Supreme Court in a separate drug case.

The high court at the end of June decided to hear arguments in a case over Merck & Co’s osteoporosis drug Fosamax, which is expected to address the question of whether the U.S. Food and Drug Administration’s rejection of a company’s proposed warning label preempts lawsuits against the company for failure to warn.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2NFj7xn

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below